studi
mainli
focus
develop
strategi
immun
regul
case
infecti
neoplast
diseas
approach
upregul
cellmedi
immun
viral
tumor
antigen
use
intracellular
bacterium
vector
target
antigen
major
histocompat
complex
mhc
class
class
ii
pathway
antigen
process
addit
exploit
adjuv
properti
vector
stimul
innat
immun
area
autoimmun
attempt
downregul
immun
respons
specif
immun
intervent
direct
autoreact
cell
studi
use
murin
model
multipl
sclerosi
approach
use
ration
design
cell
receptor
tcr
peptid
analog
recombin
viral
vector
express
tcr
compon
regul
diseas
laboratori
interest
properti
protein
foreign
self
render
immunogen
immunogenc
may
modul
vivo
case
immunoglobulin
receptor
b
cell
antigen
site
protein
antigen
bind
site
immunoglobulin
topograph
surfac
howev
case
cell
receptor
tcr
antigen
region
protein
peptid
deriv
cellular
process
express
surfac
antigenpres
cell
associ
molecul
major
histocompat
complex
mhc
cellular
compart
cell
epitop
gener
determin
whether
emerg
cell
surfac
bound
mhc
class
ii
molecul
therefor
type
cell
respons
elicit
enorm
advanc
made
last
year
understand
molecular
cellular
machineri
govern
present
antigen
immun
system
laboratori
attempt
appli
knowledg
develop
strategi
immun
regul
number
diseas
model
work
serv
two
purpos
first
believ
learn
much
mechan
immun
test
outcom
appli
current
theori
manipul
immunopatholog
state
second
heed
albert
sabin
maxim
yield
everi
whim
curios
allow
passion
inquiri
restrain
noth
limit
abil
show
eager
mind
unbecom
scholarship
wisdom
merit
select
among
innumer
problem
present
whose
solut
import
mankind
case
foreign
antigen
attempt
enhanc
immun
respons
design
effect
vaccin
viral
diseas
tumor
cell
use
facult
intracellular
bacterium
listeria
monocytogen
unusu
abil
live
grow
cytoplasm
cell
shown
recombin
form
organ
transform
express
foreign
antigen
excel
vector
target
foreign
antigen
mhc
class
pathway
antigen
process
gener
authent
cytotox
lymphocyt
ctl
epitop
area
autoimmun
attempt
regul
cell
respons
specif
immun
intervent
direct
autoreact
cell
studi
use
two
murin
model
multipl
sclerosi
first
experiment
induc
autoimmun
diseas
known
experiment
autoimmun
encephalomyel
eae
diseas
mice
rat
caus
cell
reactiv
myelin
basic
protein
use
restrict
number
variabl
v
gene
construct
receptor
approach
use
ration
design
tcr
peptid
analog
recombin
viral
vector
express
tcr
compon
regul
diseas
anoth
murin
model
multipl
sclerosi
induc
neurotrop
strain
murin
hepat
viru
case
caus
postinfecti
demyelin
event
unknown
although
cell
immun
system
implic
indirectli
identif
phenotyp
cell
elus
collabor
weiss
laboratori
attempt
determin
immun
mechan
demyelin
although
hope
studi
allow
us
design
effect
therapi
diseas
state
process
believ
may
shed
light
fundament
question
regard
regul
immun
respons
protein
antigen
project
use
unusu
intracellular
bacterium
target
antigen
appear
poorli
immunogen
immun
system
two
major
area
focus
hiv
infect
normal
immun
respons
fail
induc
steril
immun
cancer
antigen
often
strongli
homolog
selfantigen
suppress
mechan
also
effect
six
year
ago
propos
type
immun
induc
facult
intracellular
parasit
l
monocytogen
could
ideal
boost
immun
respons
foreign
antigen
unusu
properti
l
monocytogen
live
cytoplasm
host
cell
see
fig
sequest
bacterium
humor
immun
respons
requir
strong
cellmedi
immun
respons
resolv
infect
shown
l
monocytogen
enter
host
cell
taken
phagosom
unlik
intracellular
bacteria
l
monocytogen
escap
phagosom
cytoplasm
cell
disrupt
phagosom
mem
fig
antigen
secret
l
monocytogen
access
mhc
class
class
ii
pathway
antigen
process
phagocytosi
antigen
present
cell
l
monocytogen
either
b
destroy
within
lysosom
compart
peptid
may
load
onto
mhc
class
ii
molecul
c
escap
cytoplasm
cell
cytosol
compart
listeria
grow
protein
secret
process
proteosom
peptid
transport
endoplasm
reticulum
load
onto
mhc
class
molecul
e
cytosol
compart
listeria
reorgan
host
cell
actin
tail
propel
around
cell
cell
peripheri
intern
neighbor
cell
break
two
plasma
membran
colon
cell
reprint
permiss
current
biolog
ltd
london
uk
curr
opin
immunol
ration
approach
brane
primarili
action
oflisteriolysin
bacteria
replic
cytoplasm
move
peripheri
cell
form
pseudopodlik
structur
recogn
intern
adjac
cell
cycl
repeat
unusu
abil
l
monocytogen
escap
phagolysosom
restrict
live
cytoplasm
explain
bacterium
particularli
effect
vector
target
class
irestrict
pathway
antigen
process
local
bacteria
lysosom
compart
invas
ensur
antigen
express
bacterium
enter
mhc
class
ii
pathway
antigen
process
sinc
major
bacteria
kill
digest
compart
vivo
final
abil
bacterium
spread
cell
cell
without
enter
extracellular
matrix
explain
inadequaci
induc
antibodi
respons
earli
studi
show
cell
major
effector
subset
control
clear
listeri
murin
infect
hemolyt
activ
bacteria
requir
cell
induct
vivo
present
cell
vitro
role
cell
appear
less
critic
control
l
monocytogen
infect
murin
model
deplet
lymphocyt
adopt
transfer
much
less
pronounc
effect
deplet
lymphocyt
deplet
cell
primari
l
monocytogen
infect
l
monocytogen
immun
mice
margin
effect
control
l
monocytogen
challeng
although
delayedtyp
hypersensit
granuloma
format
sever
diminish
mice
treat
antibodi
strong
dth
respons
l
monocytogen
directli
relat
innat
immun
respons
bacterium
take
place
earli
infect
phagocytosi
l
monocytogen
resid
macrophag
result
secret
interleukin
il
tumor
necrosi
factor
tnf
c
activ
state
compet
destroy
invad
parasit
nitric
oxid
product
ill
secret
resid
macrophag
activ
neutrophil
help
maintain
activ
state
macrophag
increas
mhc
express
tnf
act
nk
cell
stimul
secret
interferon
ifn
facilit
expans
cell
influenc
ifn
differenti
th
phenotyp
secret
tnfc
ifn
later
infect
may
secret
macrophag
downregul
activ
thl
stage
innat
immun
consist
abil
l
monocytogen
promot
cellmedi
humor
immun
verifi
vivo
cell
respons
also
restrict
thl
phenotyp
case
intracellular
pathogen
present
decad
emerg
consensu
cell
especi
class
irestrict
cell
critic
mediat
effect
antitumor
respons
unlik
antibodi
target
cell
epitop
may
cytoplasm
locat
epitop
consist
linear
amino
acid
stretch
last
year
number
tumor
antigen
well
epitop
recogn
tumorspecif
cell
character
consequ
current
cancer
vaccin
strategi
primarili
direct
toward
rais
strong
tumorspecif
cell
respons
introduc
identifi
cell
antigen
immun
system
way
prime
immun
respons
suffici
elimin
tumor
metastas
residu
tumor
mass
seriou
problem
howev
mount
immun
respons
antigen
express
tumor
cell
often
paterson
poorli
immunogen
strong
homolog
selfprotein
addit
initi
present
immun
system
context
tumor
cell
part
poor
antigenpres
cell
like
induc
toler
antigen
rather
activ
cell
respons
abil
l
monocytogen
stimul
strong
cellmedi
immun
suggest
bacterium
may
ideal
vaccin
vector
introduc
poorli
immunogen
tumorspecif
antigen
mhc
class
class
ii
antigen
present
pathway
profession
antigenpres
cell
test
efficaci
l
monocytogen
cancer
vaccin
use
model
tumor
system
util
influenza
nucleoprotein
model
tumor
antigen
recombin
l
monocytogen
vaccin
strain
lmnp
express
np
influenza
strain
use
lmnp
previous
shown
present
k
restrict
np
epitop
vitro
induc
npspecif
ctl
vivo
provid
transplant
tumor
express
np
model
tumor
antigen
highli
tumorigen
class
pif
tumor
cell
renca
transduc
np
gene
found
therapeut
potenti
vaccin
vector
limit
tumor
growth
impress
regress
macroscop
tumor
could
demonstr
tumor
type
import
oft
cell
antitumor
immun
confirm
histolog
analysi
tumor
vivo
deplet
either
cell
subset
subset
clearli
play
role
antitumor
immun
despit
fact
tumor
mhc
class
iii
class
ii
express
induc
thu
cell
might
well
expect
sole
effector
mechan
oper
tumor
environ
nevertheless
consider
multifacet
way
l
monocytogen
stimul
immun
may
provid
explan
find
frequent
failur
immun
system
respond
tumor
antigen
subsequ
outgrowth
transform
cell
cancer
attribut
inadequaci
tumor
cell
present
antigen
toler
mechan
act
tumorspecif
cell
defici
remedi
transfect
tumor
cell
certain
cytokin
gene
ifn
gmcsf
costimulatori
ligand
either
activ
bypass
requir
cell
help
mount
protect
tumorspecif
ctl
respons
accordingli
thl
type
cytokin
profil
induc
l
monocytogen
describ
may
play
import
role
efficaci
vaccin
vector
inde
demonstr
presenc
mrna
wide
array
th
cytokin
regress
tumor
explant
vaccin
anim
shown
deplet
thltype
cytokin
ifni
tnfc
abrog
abil
l
monocytogen
protect
tumor
challeng
np
model
system
pan
et
al
unpublish
observ
induct
thl
cytokin
cellsurfac
molecul
import
celt
activ
consider
advantag
anticanc
vaccin
thu
l
monocytogen
may
ideal
vehicl
present
tumor
antigen
tumorspecif
cell
also
provid
correct
milieu
enhanc
efficaci
effector
cell
current
studi
aim
dissect
mechan
l
monocytogen
caus
regress
establish
tumor
antigenspecif
manner
examin
correl
immun
includ
type
lymphocyt
cytokin
requir
antitumor
immun
address
possibl
cellsurfac
phenotyp
tumor
cell
may
chang
respons
local
environ
provid
infiltr
thl
cell
also
expand
studi
natur
model
mous
human
tumor
could
argu
influenza
nucleoprotein
immunogen
appropri
model
tumor
antigen
fact
express
np
renca
appear
enhanc
immunogen
decreas
intrins
tumorogen
minim
tumoricid
dose
rencanp
balbc
mice
ident
parent
line
furthermor
anim
rencanp
grow
function
detect
npspecif
ctl
thu
express
tumor
np
appear
behav
indistinguish
endogen
tumor
antigen
howev
answer
critic
current
expand
studi
endogen
mous
tumor
antigen
mous
mastocytoma
murin
leukemia
retrovir
product
endogen
express
tissuespecif
antigen
melanin
pathway
tyrosinas
tyrosinaserel
protein
express
murin
melanoma
also
investig
potenti
l
monocytogen
vector
vaccin
breast
cancer
use
neu
transgen
mous
oncogen
express
breast
tissu
test
abil
vaccin
approach
spontan
aris
breast
tumor
anim
model
antigen
cellular
immun
shown
play
signific
role
control
viral
infect
yet
mani
viral
infect
human
immun
respons
unabl
either
prevent
clear
infect
mani
individu
one
devast
hiv
increas
evid
retrovirus
induc
humor
cellular
immun
inde
sever
year
sinc
hivspecif
ctl
discov
healthi
seroposit
patient
sinc
mani
studi
confirm
presenc
ctl
hiv
human
specif
gag
pol
nef
tat
env
gene
product
role
ctl
immun
clearanc
retrovirus
still
entir
clear
number
studi
suggest
ctl
may
play
major
role
protect
hiv
simian
counterpart
exampl
correl
low
viral
titer
presenc
gagspecif
ctl
peripher
blood
shown
sivinfect
macaqu
studi
encourag
mani
investig
focu
ctl
immunogen
prerequisit
antihiv
vaccin
hiv
infect
antivir
antibodi
produc
abil
control
spread
viru
clearli
ineffect
primari
antigen
intact
viru
expos
humor
immun
system
envelop
glycoprotein
mutat
rate
env
gene
howev
high
thu
viral
escap
mutant
emerg
evad
humor
immun
respons
addit
antibodi
major
envelop
protein
shown
ineffect
protect
viral
infect
also
implic
diseas
progress
paterson
low
rate
mutat
gene
code
core
protein
major
advantag
vaccin
aim
enhanc
cellular
arm
immun
respons
virus
influenza
hiv
mechan
avoid
humor
immun
respons
contrast
antibodi
ctl
often
broadli
crossreact
easili
invok
core
protein
readili
target
classi
restrict
pathway
antigen
recognit
prospect
similar
vaccin
aim
boost
ctl
respons
hiv
encourag
sinc
number
studi
shown
ctl
respons
gag
nef
pol
gene
product
restrict
conserv
sequenc
protein
present
wide
number
hla
class
allel
therefor
despit
reserv
good
evid
class
irestrict
arm
cellular
immun
respons
may
play
help
role
reduc
hiv
diseas
progress
infect
individu
addit
pivot
role
design
prophylact
antihiv
vaccin
aspect
immun
respons
hiv
recent
receiv
great
deal
interest
role
balanc
humor
cellular
immun
regul
thl
subset
diseas
progress
although
still
controversi
suggest
humor
immun
respons
far
benefici
even
ineffect
hiv
infect
may
actual
harm
impair
abil
host
mount
protect
cellular
immun
respons
thesi
support
diseas
model
thu
long
known
either
humor
cellmedi
arm
predomin
immun
respons
infecti
agent
particularli
intracellular
pathogen
leishmania
major
mycobacterium
lepra
result
either
resist
suscept
diseas
support
suggest
may
also
case
hiv
infect
studi
hiv
individu
indic
declin
cell
prolifer
product
concomit
increas
b
cell
activ
aid
symptom
progress
discuss
cell
respons
l
monocytogen
infect
predispos
th
respons
addit
shown
intracytosol
locat
bacterium
effect
target
recombin
protein
endogen
antigenprocess
advantag
use
l
monocytogen
vaccin
vector
natur
infect
oral
rout
shown
effect
administ
oral
vaccin
gener
cellmedi
immun
recombin
antigen
case
hiv
infect
oral
immun
could
result
induct
mucos
immun
respons
site
infect
shown
vaccin
recombin
l
monocytogen
provid
ctl
respons
effect
viral
infect
mucos
surfac
lung
mice
immun
l
monocytogen
mutant
express
either
fulllength
influenza
viru
nucleoprotein
construct
express
mhc
class
k
bind
epitop
subsequ
infect
intranas
influenza
viru
pulmonari
viral
titer
substanti
reduc
immun
mice
rel
naiv
mice
mice
infect
wildtyp
l
monocytogen
current
examin
natur
mucos
immun
respons
siv
antigen
deliv
l
monocytogen
although
strong
cell
respons
predict
obviou
weak
humor
respons
detect
listeria
deliv
parenter
rout
would
also
prevail
gut
current
thought
mucos
immun
respons
solubl
antigen
predispos
respons
presum
requir
cytokin
secret
iga
respons
thu
interest
determin
would
true
antigen
deliv
intracellular
pathogen
capabl
induc
cytokin
drive
cell
respons
direct
given
l
monocytogen
facult
intracellular
bacterium
possibl
bacterium
extracellular
particular
environ
compet
therefor
induc
iga
respons
secret
peyer
patch
b
cell
intestin
epitheli
lymphocyt
particularli
import
establish
bacterium
ever
use
oral
recombin
vaccin
vector
either
neoplast
infecti
diseas
howev
problem
aris
distinguish
specif
iga
produc
respons
iisteri
antigen
iga
natur
occur
gut
owe
respons
commens
bacteria
nevertheless
use
l
monocytogen
express
foreign
antigen
chemic
distinct
prokaryot
protein
use
report
antigen
quantit
immun
respons
protein
secret
listeria
induc
selfantigen
eae
one
beststudi
exampl
experiment
induc
cellmedi
autoimmun
diseas
inflammatori
diseas
central
nervou
system
cn
induc
inject
myelin
basic
protein
mbp
common
compon
cn
complet
freund
adjuv
cfa
result
stimul
popul
cell
mediat
eae
transfer
diseas
naiv
recipi
eae
resembl
multipl
sclerosi
ms
human
demyelin
diseas
unknown
etiolog
clinic
cours
histopatholog
addit
presenc
oft
cell
respons
mbp
peripher
blood
ms
patient
add
credenc
studi
eae
anim
model
explor
immun
regul
human
demyelin
diseas
found
cell
mediat
eae
mous
rat
model
use
limit
number
tcr
gene
initi
observ
cell
gener
mous
specif
pij
strain
lewi
rat
respons
encephalitogen
determin
mbp
show
restrict
usag
variabl
region
gene
express
germ
line
also
junction
region
gener
tcr
gene
rearrang
interest
find
variabl
region
use
mous
rat
even
though
antigen
mhc
molecul
recogn
differ
function
noncrossreact
mice
rat
v
use
combin
vc
led
concept
call
vregion
diseas
hypothesi
state
specif
vcv
combin
independ
associ
antigen
mhc
caus
autoimmun
diseas
immun
mbpspecif
cell
attenu
irradi
shown
prevent
induct
eae
rat
subsequ
immun
mbp
cfa
monoclon
antibodi
mab
direct
paterson
specif
tcr
variabl
region
block
express
eae
suppress
ongo
diseas
presum
mechan
action
therapi
block
tcr
cell
respons
diseas
mab
induc
cellular
immun
respons
direct
toward
peptid
deriv
tcr
bound
mhc
molecul
encephalitogen
cell
although
well
establish
cell
mediat
eae
mous
rat
precis
phenotyp
effector
cell
antiidiotyp
immun
respons
tcr
determin
yet
unknown
rat
cell
implic
mous
model
grow
evid
cell
major
regulatori
cell
eae
cell
strongli
implic
tcr
peptideinduc
unrespons
exampl
mice
deplet
cell
antibodymedi
clearanc
knockout
gene
show
less
resist
relaps
episod
diseas
addit
although
tcr
peptidespecif
cell
isol
mice
recov
mbpinduc
eae
thought
regul
diseas
indirectli
via
cell
mediat
given
mous
cell
unlik
rat
counterpart
express
class
ii
mhc
appear
unlik
encephalitogen
cell
could
cognat
target
regulatori
cell
mous
model
studi
therefor
concentr
determin
presenc
cdsregulatori
cell
mbpreactiv
cell
peripher
mous
repertoir
role
may
regul
eae
mainten
toler
gener
mous
addit
provid
basi
possibl
autoimmun
therapi
believ
studi
also
address
whole
issu
immun
regul
andor
suppress
activ
cellular
immun
respons
inde
class
irestrict
cell
play
role
immun
regul
question
aris
concern
whether
current
approach
induc
immunoregulatori
cell
immun
tcr
peptid
appropri
cell
respons
prime
solubl
protein
peptid
antigen
almost
alway
result
present
antigen
via
exogen
cellular
pathway
prime
class
iirestrict
cell
induc
class
irestrict
cell
antigen
peptid
must
usual
deriv
intracellular
process
newli
synthes
protein
within
cell
cytoplasm
socal
endogen
pathway
arm
immun
respons
clearli
evolv
deal
cytoplasm
infect
viral
bacteri
intracellular
parasit
suggest
may
best
target
vector
type
number
year
recombin
vaccinia
viru
gold
standard
studi
mhc
class
irestrict
cell
respons
use
vaccinia
vector
high
level
express
foreign
gene
becom
widespread
protocol
larg
routin
homolog
dna
recombin
occur
normal
replic
pox
virus
foreign
dna
easili
insert
viral
genom
thu
use
vaccinia
viru
gene
vector
target
v
tcr
gene
cellular
arm
immun
respons
made
two
construct
one
express
gene
conalbumin
specif
cell
hybridoma
express
gene
pigeon
cytochromecspecif
cell
hybridoma
determin
whether
thu
possibl
mechan
concomit
reduct
mbpreactiv
cell
eae
mice
could
simpl
elimin
tcr
beat
cell
peripheri
immun
mice
ctl
kill
order
compar
number
lymph
node
cell
mice
immun
naiv
mice
two
color
fluorescentactiv
cell
sort
fac
analysi
perform
percentag
cell
significantli
alter
among
naiv
group
mice
howev
note
number
mbprespons
cell
naiv
mice
infrequ
expans
vivo
prime
mbp
also
alter
total
number
cell
measur
fac
analysi
thu
possibl
even
reduct
mbpreactiv
cell
small
detect
fac
analysi
could
impact
immun
respons
anim
eae
test
hypothesi
use
mous
model
transgen
tcr
pcyt
cspecif
cell
isol
k
mous
whose
tcr
use
first
verifi
normal
k
mice
immun
vv
vv
show
diminish
pcyt
c
prolif
respons
reduct
respons
similar
effect
see
mbp
mice
immun
eidelman
et
al
unpublish
observ
cell
tcr
transgen
k
mous
adopt
transfer
syngen
mice
receiv
vacv
vaccin
anim
subsequ
immun
pcyt
c
pcyt
crespons
cell
significantli
reduc
anim
compar
control
group
determin
fac
analysi
drain
lymph
node
howev
would
activ
pcyt
c
remain
similar
level
indic
immun
vv
appear
influenc
activ
cell
current
verifi
find
mbp
model
repeat
experi
use
transgen
mous
construct
mbpreactiv
encephalitogen
cell
line
studi
immun
respons
selfantigen
examin
unusu
autoantigen
cell
respons
heme
moieti
hemoprotein
discov
year
ago
nonprotein
selfantigen
prosthet
group
number
hemoprotein
ubiquit
tissu
includ
thymu
therefor
consider
interest
note
cell
freshli
explant
naiv
mice
rais
potent
prolif
respons
hein
primari
mlr
suggest
heme
reactiv
cell
occur
high
frequenc
peripheri
cell
mice
haplotyp
sjl
asw
exhibit
high
respond
phenotyp
stimul
heme
bulk
primari
assay
wherea
mice
haplo
paterson
type
balbc
low
respond
use
limit
dilut
analysi
found
potent
primari
prolif
respons
tcell
mice
reflect
high
frequenc
hemerespons
cell
peripheri
frequenc
compar
frequenc
allorespons
cell
report
other
primari
mix
lymphocyt
reaction
mlr
keep
low
respond
phenotyp
bulk
primari
assay
hemerespons
cell
occur
lower
frequenc
unprim
mice
notabl
even
figur
high
comparison
frequenc
cell
respond
foreign
protein
antigen
horsesho
crab
hemocyanin
oft
cell
sjl
mice
respond
hchi
even
expans
popul
vivo
prime
respect
respons
hein
differ
self
antigen
cell
respons
healthi
anim
gener
detect
consider
manipul
also
foreign
protein
vivo
expans
also
shown
cell
reactiv
hein
similar
cell
reactiv
peptid
antigen
show
strict
mhc
restrict
use
divers
v
gene
featur
distinguish
heme
superantigen
mitogen
also
stimul
potent
primari
mlr
exhibit
degener
mhc
restrict
case
superantigen
restrict
v
gene
usag
use
mass
spectral
analysi
natur
process
peptid
bound
mhc
class
ii
molecul
demonstr
set
ofpeptid
cell
puls
heme
quit
differ
isol
cell
grown
absenc
heme
suggest
cell
may
stimul
heme
via
alloreactivelik
mechan
current
use
phage
display
librari
approach
determin
heme
mediat
effect
bind
set
peptid
previous
present
immun
system
facilit
interact
mhc
class
h
presenc
high
frequenc
hemereact
cell
peripher
lymphoid
organ
mice
absenc
obviou
patholog
anim
led
us
investig
whether
hemecontain
protein
could
act
antigen
hemereact
cell
clone
surprisingli
found
abil
hemoprotein
stimul
cell
clone
speciesspecif
thu
mammalian
cytochromesc
ineffect
avian
cytochrom
potent
free
heme
poor
antigen
mammalian
protein
howev
could
revers
denatur
protein
suggest
nativ
molecul
resist
process
murin
antigenpres
cell
thu
heme
appear
evad
immun
recognit
mice
sequestr
cryptic
epitop
hemoprotein
investig
whether
popul
hemereact
cell
could
play
role
patholog
diseas
heme
level
elev
normal
pathway
heme
degrad
liver
fail
function
well
known
mani
human
autoimmun
diseas
precipit
viral
infect
although
immunemedi
damag
often
trace
autoimmun
cell
appear
viral
infect
trigger
respons
either
induc
inflammatori
th
cytokin
break
toler
autoantigen
molecular
mimicri
mechan
wherebi
cell
respons
viral
peptid
sequenc
cross
react
homolog
selfantigen
viral
infect
implic
initi
autoimmun
diseas
obscur
exact
etiolog
diseas
case
human
demyelin
diseas
ms
although
decad
research
patholog
immunolog
biochem
aspect
diseas
taken
place
etiolog
pathogenesi
ms
still
unclear
ms
inflammatori
demyelin
diseas
cn
lesion
heavili
infiltr
lymphocyt
macrophag
inflamm
cn
presenc
increas
mhc
express
resid
cell
plaqu
area
suggest
autoimmunemedi
damag
cn
epidemiolog
evid
howev
suggest
may
viral
infect
involv
etiolog
ms
mani
attempt
made
identifi
andor
isol
virus
cn
blood
ms
patient
howev
despit
report
success
year
case
viru
unequivoc
establish
caus
agent
ms
quit
possibl
therefor
diseas
fundament
autoimmun
origin
viral
infect
may
trigger
respons
although
clear
viru
involv
etiolog
ms
infect
anim
virus
provid
good
model
system
studi
chronic
demyelin
human
among
intracrani
infect
coronaviru
mous
hepat
viru
mhv
model
mice
surviv
acut
enceph
undergo
chronic
demyelin
diseas
accompani
inflamm
ms
uncertainti
regard
mechan
demyelin
extent
immun
autoimmun
reaction
contribut
collabor
laboratori
weiss
use
coronaviru
mhv
strain
infect
mice
model
system
studi
role
immun
system
viral
induc
demyelin
murin
cn
detect
viral
particl
oligodendrocyt
led
theori
mhvinduc
demyelin
directli
owe
viral
damag
cell
howev
recent
shown
immunosuppress
irradi
infect
mice
prevent
demyelin
despit
correspond
increas
viral
titer
togeth
find
demyelin
restor
adopt
transfer
thyl
splenocyt
suggest
cell
may
mediat
demyelin
contrast
studi
recent
shown
cell
defici
gene
knockout
mice
undergo
demyelin
indic
cell
absolut
necessari
demyelin
howev
frequenc
demyelin
observ
anim
low
result
may
attribut
either
role
cell
demyelin
normal
mice
ineffici
infect
rate
owe
use
low
inocul
dose
wildtyp
knockout
mice
pfu
although
infect
could
reliabl
establish
use
c
attenu
variant
pfu
knockout
mice
question
rel
import
cell
demyelin
diseas
remain
doubt
sinc
induc
demyelin
lesion
low
frequenc
wildtyp
knockout
mice
recent
studi
attempt
resolv
question
carri
vivo
deplet
cell
normal
mice
inject
pfu
wildtyp
similarli
extend
earlier
studi
address
role
cell
examin
effect
cell
deplet
variou
timepoint
postinfect
incid
demyelin
attempt
made
examin
role
cell
demyelin
earli
stage
infect
commenc
deplet
subset
dpi
unfortun
six
mice
group
infect
experi
deplet
cell
four
deplet
cell
die
dpi
result
unsurpris
given
viral
titer
peak
dpi
cell
paterson
known
import
mhv
clearanc
order
reduc
risk
fatal
experi
repeat
commenc
cell
deplet
delay
dpi
viral
titer
begin
declin
thymectom
mice
spinal
cord
collect
dpi
examin
toluidin
blue
stain
demyelin
lesion
describ
mice
examin
control
celldeplet
group
contain
demyelin
lesion
also
perform
experi
begin
deplet
oft
cell
day
viral
titer
wane
enabl
us
also
examin
effect
deplet
cell
subset
togeth
addit
cell
separ
without
risk
persist
viral
infect
saw
signific
differ
group
mice
regard
demyelin
dpi
compar
control
group
includ
five
mice
cell
deplet
result
suggest
neither
cell
major
effectot
mhvinduc
demyelin
diseas
exclud
minor
role
cell
effector
demyelin
given
result
stohlman
colleagu
show
demyelin
reduc
mice
immunosuppress
irradi
dpi
earlier
restor
demyelin
adopt
transfer
thyl
splenocyt
seem
probabl
cell
may
play
role
induct
demyelin
diseas
rather
major
effector
possibl
compon
earli
demyelin
prior
clearanc
infecti
viru
may
owe
direct
virusmedi
lysi
oligodendrocyt
howev
seem
unlik
respons
major
demyelin
aris
infecti
viru
longer
detect
failur
suppress
demyelin
via
irradi
dpi
later
would
consist
role
radiationresist
effector
macrophag
depend
activ
via
cell
initi
stage
diseas
regard
although
cell
play
critic
role
demyelin
experiment
autoimmun
encephalomyel
yet
undefin
role
ms
macrophag
also
conspicu
inflammatori
lesion
demyelin
diseas
current
pursu
sourc
cn
inflamm
anim
examin
express
cytokin
cn
variou
time
infect
postinfect
demyelin
phase
obviou
outcom
immun
respons
protein
antigen
whether
foreign
self
govern
complex
seri
vivo
event
includ
antigenprocess
pathway
access
antigen
level
costimulatori
ligand
antigenpres
cell
cytokin
milieu
immun
respons
develop
possibl
induct
ofimmunoregulatori
cell
brief
articl
outlin
studi
area
engag
excit
laboratori
current
approach
use
live
recombin
vector
manipul
paramet
howev
given
organ
precis
stimuli
immun
system
evolv
believ
studi
immun
respons
report
antigen
express
shed
light
fundament
immun
mechan
